EUROPEAN BIOTECH ACQUTN CORP's ticker is EBACU and the CUSIP is G3167F110. A total of 19 filers reported holding EUROPEAN BIOTECH ACQUTN CORP in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $755 | -99.9% | 74,907 | 0.0% | 0.01% | +37.5% |
| Q3 2022 | $742,000 | +1.5% | 74,907 | 0.0% | 0.01% | 0.0% |
| Q2 2022 | $731,000 | 0.0% | 74,907 | 0.0% | 0.01% | +60.0% |
| Q1 2022 | $731,000 | -1.3% | 74,907 | 0.0% | 0.01% | +25.0% |
| Q4 2021 | $741,000 | -0.4% | 74,907 | 0.0% | 0.00% | -20.0% |
| Q3 2021 | $744,000 | -0.4% | 74,907 | 0.0% | 0.01% | -28.6% |
| Q2 2021 | $747,000 | -7.2% | 74,907 | -6.5% | 0.01% | -12.5% |
| Q1 2021 | $805,000 | – | 80,131 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Exos Asset Management LLC | 50,000 | $502,000 | 0.39% |
| Arena Capital Advisors, LLC- CA | 300,000 | $3,020,000 | 0.30% |
| MMCAP International Inc. SPC | 250,000 | $2,516,000 | 0.25% |
| PERISCOPE CAPITAL INC. | 350,000 | $3,523,000 | 0.14% |
| Kepos Capital LP | 175,000 | $1,761,000 | 0.11% |
| Ghisallo Capital Management LLC | 150,000 | $1,508,000 | 0.10% |
| Shaolin Capital Management LLC | 200,000 | $2,013,000 | 0.08% |
| Atalaya Capital Management LP | 40,000 | $402,000 | 0.08% |
| Radcliffe Capital Management, L.P. | 200,000 | $2,013,000 | 0.08% |
| GABELLI & Co INVESTMENT ADVISERS, INC. | 57,789 | $581,000 | 0.07% |